Sambrana, Rowena T.
HRN: 29-13-33 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2026
CEFUROXIME 1.5GM (VIAL)
07/10/2026
07/10/2026
IV
1.5gms
LD
UTI
Checking Initial Appropriateness
07/10/2026
CEFUROXIME 750MG (VIAL)
07/10/2026
07/16/2026
IV
750mg
Q12
UTI
Checking Initial Appropriateness